Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Moderate hypofractionated radiotherapy for prostate cancer: 3-year toxicity results of a multicentre randomized phase 3, non-inferiority trial

Published:2024-04 Issue: Volume:193 Page:110089
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Fonteyne V.^ORCID,Berghen C.,Van Praet C.,Vanderstraeten B.^ORCID,Verbeke S.,Villeirs G.^ORCID,Colman R.,Vanneste B.,Ost P.^ORCID,De Meerleer G.,Lumen N.

Funder

Stichting Tegen Kanker

Publisher

Elsevier BV

Reference21 articles.

1. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;Lancet Oncol.,2016

2. Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer;Catton;J. Clin. Oncol.,2017

3. Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer;Lee;J. Clin. Oncol.,2016

4. Moderate hypofractionation in high-risk, organ confined prostate cancer: final results of a phase III randomized trial;Arcangeli;J. Clin. Oncol.,2017

5. From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: primary end point analysis of the multicenter phase II hypo-FLAME 2.0 trial;De Cock;Radiother. Oncol.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP